[
    [
        {
            "time": "2021-06-15",
            "original_text": "2021年全球制药企业TOP50出炉！罗氏再次夺冠，5家中国药企上榜",
            "features": {
                "keywords": [
                    "全球制药企业",
                    "TOP50",
                    "罗氏",
                    "中国药企"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2021年全球制药企业TOP50出炉！罗氏再次夺冠，5家中国药企上榜",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-06-15",
            "original_text": "百济神州和恒瑞医药向CXO说不 | 海斌访谈",
            "features": {
                "keywords": [
                    "百济神州",
                    "恒瑞医药",
                    "CXO"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "百济神州和恒瑞医药向CXO说不 | 海斌访谈",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-06-15",
            "original_text": "2021全球药企50强出炉！云南白药、中生制药、恒瑞、上药、石药入列",
            "features": {
                "keywords": [
                    "全球药企",
                    "50强",
                    "云南白药",
                    "中生制药",
                    "恒瑞",
                    "上药",
                    "石药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2021全球药企50强出炉！云南白药、中生制药、恒瑞、上药、石药入列",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        }
    ]
]